These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12189729)

  • 1. Regulatory considerations in the development of protein pharmaceuticals.
    Beatrice MG
    Pharm Biotechnol; 2002; 14():405-56. PubMed ID: 12189729
    [No Abstract]   [Full Text] [Related]  

  • 2. Current regulatory and legal considerations for follow-on biologics.
    Kingham RF; Lietzan E
    Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615
    [No Abstract]   [Full Text] [Related]  

  • 3. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commemorating the 50th anniversary of the Drug Amendments of 1962.
    Hutt PB; Temple R
    Food Drug Law J; 2013; 68(4):449-65. PubMed ID: 24552082
    [No Abstract]   [Full Text] [Related]  

  • 5. Reform, regulation, and pharmaceuticals--the Kefauver-Harris Amendments at 50.
    Greene JA; Podolsky SH
    N Engl J Med; 2012 Oct; 367(16):1481-3. PubMed ID: 23075174
    [No Abstract]   [Full Text] [Related]  

  • 6. Show drugs work before selling them.
    Sipp D; McCabe C; Rasko JE
    Nature; 2017 Mar; 543(7644):174-175. PubMed ID: 28277530
    [No Abstract]   [Full Text] [Related]  

  • 7. Reflections on historical, scientific, and legal issues relevant to designing approval pathways for generic versions of recombinant protein-based therapeutics and monoclonal antibodies.
    Dudzinski DM
    Food Drug Law J; 2005; 60(2):143-260. PubMed ID: 16094771
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemistry, manufacturing, and controls information in NDAs and ANDAs, supplements, annual reports, and other regulatory filings.
    Sheinin E; Williams R
    Pharm Res; 2002 Mar; 19(3):217-26. PubMed ID: 11934225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of drugs and devices: an evolution.
    Merrill RA
    Health Aff (Millwood); 1994; 13(3):47-69. PubMed ID: 7927161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Path to approval proves rocky for copycat biodrugs.
    Wadman M
    Nature; 2005 Nov; 438(7065):154-5. PubMed ID: 16281004
    [No Abstract]   [Full Text] [Related]  

  • 11. Commissioner Kessler's agbio legacy.
    Hoyle R
    Nat Biotechnol; 1997 Jan; 15(1):2. PubMed ID: 9035091
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer drug approval in the United States, Europe, and Japan.
    Milsted RA
    Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686
    [No Abstract]   [Full Text] [Related]  

  • 13. Tougher rules aim to prevent gene flow into crops.
    Hoag H
    Nature; 2003 Mar; 422(6928):103. PubMed ID: 12634744
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent developments help the defense of drug companies in 10b-5 cases.
    Salpeter AN; Hutchins H
    Food Drug Law J; 1996; 51(3):345-53. PubMed ID: 11797711
    [No Abstract]   [Full Text] [Related]  

  • 15. International Conference on Harmonisation; guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability--FDA. Notice.
    Fed Regist; 1998 Sep; 63(185):51074-84. PubMed ID: 10185809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked?
    Shulman SR; Brown JS
    Food Drug Law J; 1995; 50(4):503-31. PubMed ID: 10343017
    [No Abstract]   [Full Text] [Related]  

  • 17. Fresh from the biotech pipeline-2014.
    Morrison C
    Nat Biotechnol; 2015 Feb; 33(2):125-8. PubMed ID: 25658270
    [No Abstract]   [Full Text] [Related]  

  • 18. Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VI.
    Darrow JJ; Avorn J; Kesselheim AS
    N Engl J Med; 2017 Dec; 377(23):2278-2286. PubMed ID: 29211663
    [No Abstract]   [Full Text] [Related]  

  • 19. The FDA: a dromedary tale.
    Nat Biotechnol; 1997 Jan; 15(1):1. PubMed ID: 9035089
    [No Abstract]   [Full Text] [Related]  

  • 20. Food and Drug Administration Drug Approval Process: A History and Overview.
    Williams CT
    Nurs Clin North Am; 2016 Mar; 51(1):1-11. PubMed ID: 26897420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.